Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Parkinson's disease according to a specific set of medical diagnostic standards known as the UK PD Brain Bank criteria.
- People who have been diagnosed with a related condition called a "parkinsonian syndrome," which includes multiple system atrophy, progressive supranuclear palsy, dementia with Lewy body, or corticobasal syndrome.
- People who do not have Parkinson's disease or a parkinsonian syndrome themselves, but are considered "at risk" — this includes people who are a blood relative of someone diagnosed with Parkinson's disease or a parkinsonian syndrome, people who carry a known gene change linked to a genetic form of Parkinson's disease, people diagnosed with idiopathic REM sleep behaviour disorder (a sleep condition where people act out their dreams), or people showing early warning signs of Parkinson's disease as defined by specific international medical guidelines.
- People who are enrolled in the French social security system.
- People aged over 10 years.
Who may not be able to join:
- People who are under legal protection (for example, under guardianship or a similar legal arrangement).
- People who do not give their consent to take part in the research.
- For an optional skin biopsy procedure only: people who have a significant blood clotting disorder or who are taking blood-thinning medication.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jean Christophe MD CORVOL, PU-PH, UMRS 1127
Phone: 33 1 42 16 57 66
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease progression; Motor and non-motor complications; Modification of antiparkinsonian treatment doses
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.